Yeong-Woo Jo

Title: Yeong-Woo Jo: Innovator in Pharmaceutical Conjugates

Introduction

Yeong-Woo Jo is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug conjugates. His work focuses on enhancing the efficacy of therapeutic agents through advanced chemical formulations.

Latest Patents

Yeong-Woo Jo holds a patent for a three-branched polyethylene glycol-G-CSF conjugate. This invention relates to a conjugate of general formula (1), where the bonding ratio of three-branched polyethylene glycol (PEG) and G-CSF is 1:1 (mol/mol). The PEG used has an average molecular weight ranging from 200 to 45,000 daltons. The patent also includes a pharmaceutical composition comprising this conjugate and a method for its preparation.

Career Highlights

Throughout his career, Yeong-Woo Jo has worked with prominent companies in the pharmaceutical industry. He has been associated with Dong-A Pharm. Co., Ltd. and Dong-A Socio Holdings Co., Ltd. These experiences have allowed him to apply his innovative ideas in practical settings, contributing to advancements in drug development.

Collaborations

Yeong-Woo Jo has collaborated with several professionals in his field, including Hyun-Kyu Jeon and Hye-In Jang. These collaborations have fostered a productive environment for research and development, leading to significant advancements in pharmaceutical technologies.

Conclusion

Yeong-Woo Jo is a distinguished inventor whose work in pharmaceutical conjugates has the potential to impact the treatment of various medical conditions. His innovative approach and dedication to research continue to drive advancements in the field.